Background: Endothelin-1 (ET-1), a vasoconstrictive and pro-inflammatory peptide, is associated with several cardiovascular risk factors and outcomes. We aimed to investigate the association of plasma ET-1 levels and renal function among young and healthy adults. Methods: Individuals aged 25-41 years were enrolled in a population-based cohort study. Main exclusion criteria were established kidney disease, cardiovascular diseases, diabetes mellitus and a body mass index > 35 kg/m 2 .
Introduction
Chronic kidney disease (CKD) represents a growing public health burden, which comes along with aging societies and rising prevalence of cardiovascular diseases and diabetes [1] [2] [3] [4] . CKD is a major cause of morbidity and mortality [4] [5] [6] . Consequently, early detection and prevention of CKD is of major importance [7] .
Endothelin-1 (ET-1) is a 21-amino-acid, mainly endothelium-derived, peptide with vasoconstrictive, inflammatory and mitogenic properties [8] [9] [10] [11] . Elevated ET-1 levels have been associated with hypertension, endothelial dysfunction and atherosclerotic diseases [9, [12] [13] [14] [15] [16] [17] . Mostly experimental studies have also indicated that ET-1 is involved in regulation of renal function, but population-based studies on this issue are sparse [18] [19] [20] [21] [22] .
Historically, the determination of plasma ET-1 levels has been time-consuming and cost-intensive. However, the advent of simple high-sensitivity assays lately enabled rapid determination plasma-derived ET-1 [23, 24] . These novel assays simplified the assessment of ET-1 levels and enable its determination in large population-based studies. In order to gain potential further insights into the role of the endothelin system in the regulation of kidney function, we evaluated the relationships of ET-1 with kidney parameters among young and healthy individuals without established kidney diseases.
Materials and methods

Study participants
The "Genetic and phenotypic determinants of blood pressure and other cardiovascular risk factors" (GAPP) study is an ongoing prospective population-based cohort study among young and healthy adults in the Principality of Liechtenstein. The detailed study design has been previously published [25] . In brief, all inhabitants of the Principality of Liechtenstein aged between 25 and 41 years were invited to participate in this study. Our main exclusion criteria were established kidney disease, known cardiovascular disease or diabetes mellitus, a body mass index (BMI) > 35 kg/m 2 or any other severe illness. Each participant gave written informed consent and the Local Ethical Commission approved the study protocol. This study has been conducted by following the tenets of the Declaration of Helsinki.
Between 2010 and 2013, we enrolled 2170 individuals. For the purpose of this analysis, we excluded 30 individuals with missing information on either plasma ET-1, plasma creatinine, urinary albumin, blood pressure (BP) or physical activity. We also excluded one participant with a plasma creatinine level of 331.5 μmol/L. Thus, we included 2139 individuals in the present study.
Blood and urine sampling
Fasting venous blood and morning urinary samples were collected from every participant. After centrifugation, the samples were immediately stored at -80 °C. ET-1 was obtained from frozen EDTA plasma samples by using a high-sensitivity, single-molecule counting assay (Erenna ® Immunoassay System, Singulex, Inc., Alameda, CA, USA) [24] . Our ET-1 assay's limits of blank and quantification were 0.07 pg/mL and 0.33 pg/mL, respectively. Inter-assay coefficients of variation were 7% at an ET-1 concentration of 1.2 pg/mL and 6% at an ET-1 concentration of 1.8 pg/mL [24] .
Plasma levels of creatinine, cystatin C, N-terminal pro brainnatriuretic peptide (NT-pro-BNP), high-sensitivity C reactive protein (hs-CRP), low-density lipoprotein cholesterol (LDL-C), as well as urinary levels of creatinine and albumin were determined in fresh samples using a Roche Cobas 6000 analyzer (F. Hoffmann-La Roche Ltd., Switzerland). Urinary sodium, creatinine and albumin levels were also measured using a Roche Cobas 6000 analyzer. Glycated hemoglobin (HbA 1c ) was analyzed using high performance liquid chromatography (Bio-Rad D-10, Bio-Rad Laboratories AG, Switzerland) [25] . We calculated the estimated 24-h albuminuria and a urinary albumin to creatinine ratio (UACR) of at least 30 mg/24 h was defined as an albuminuria, as previously described [26] . The glomerular filtration rate (eGFR) was estimated using the chronic kidney disease epidemiology collaboration (CKD-EPI) formula based on plasma creatinine [27] . For the estimation of the 24 h urinary sodium excretion, we used morning spot urine samples and applied Kawasaki's formula [28] . Prediabetes/diabetes was defined as a HbA 1c level > 5.7% [29] .
Other study variables
Information about personal, medical, lifestyle and nutritional factors was collected using standardized questionnaires. The highest education level achieved was categorized into 'high school', 'college' or 'university' degree. Self-assessed smoking status was classified as current, former or never smoking. We dichotomized drinking habits as drinkers versus non-drinkers. The individual physical activity questionnaire (IPAQ) was applied for the evaluation of the subjects' physical activity level [25] .
We obtained conventional BP measurements after at least 5 min of rest using a validated oscillometric device (Microlife BP3AG1, Microlife AG, Switzerland). The mean of the second and third measurement was used for BP-related analyses. Hypertension was defined as a systolic BP ≥ 140 mmHg, a diastolic BP ≥ 90 mmHg or the intake of antihypertensive drugs. Body weight and height were measured in a standardized manner [25] . BMI was calculated by dividing weight in kilograms by height in meters squared. Bioelectrical impedance was used to estimate the body composition of all subjects using an established methodology and a validated device (BIA ego fit, 2010, Germany) [25] .
Statistical analyses
We stratified the baseline characteristics by quartiles of ET-1. The distribution pattern of continuous variables was assessed using kurtosis, skewness and visual inspection of the histograms. The baseline characteristics of continuous variables were presented as medians (interquartile range) and compared using ANOVA or Kruskal-Wallis tests as appropriate. Categorical variables were compared using χ 2 -tests.
We used multivariable linear regression models to compare the β-coefficients of creatinine, cystatin C and the eGFR across quartiles of ET-1 and to adjust for potential confounders. All models were adjusted for a predefined set of covariates, including age, sex, BMI, LDL-C, HbA 1c , systolic BP, hs-CRP, estimated urinary sodium excretion, estimated body water and muscle mass, physical activity, smoking status, alcohol consumption and education level. Since all associations were approximately linear, additional analyses were performed using ET-1 as a log-transformed continuous variable as the predictor of interest. Additionally, a logistic regression model was constructed to assess the relationship between ET-1 levels and UACR, using the same variables indicated above.
Stratified regression models were applied to assess the relationships between ET-1 and eGFR across pre-specified subgroups, including age, sex, BMI, prediabetes, hypertension and smoking, and formal differences were assessed using multiplicative interaction terms in the non-stratified models. Categorical variables were introduced in all multivariable models using binary indicator variables. All statistical analyses were performed with SAS version 9.4 (SAS Institute, Inc., Cary, NC, USA). A p-value of < 0.05 was pre-specified to indicate statistical significance.
Results
Baseline demographics of the 2139 subjects according to quartiles of ET-1 are displayed in Table 1 . Quartile-specific median ET-1 levels were 1.86, 2.33, 2.76, and 3.49 pg/mL.
The median (interquartile range) eGFR was 112 (103-118) mL/min/1.73 m 2 . Being in a higher ET-1 quartile was significantly associated with male sex, and higher levels of BP, BMI, LDL-C, hs-CRP and estimated urinary sodium excretion. Current smokers and individuals with higher physical activity levels had also higher ET-1 levels. There was a significant linear increase across ET-1 quartiles for creatinine, cystatin C and eGFR (p < 0.0001, p < 0.0001 and p = 0.0043, respectively). We found nonlinear differences across ET-1 quartiles for body water (p = 0.011), alcohol intake (p = 0.006) and urinary albumin-to-creatinine ratio (p = 0.022).
Regression analyses for the association of creatinine, cystatin C, the eGFR and albuminuria with plasma ET-1 levels are displayed in Table 2 . The significant relationships of ET-1 with creatinine, cystatin C and eGFR on univariable assessment persisted after adjustment for . BMI, body mass index; BP, blood pressure; TRT, treatment; NT-proBNP, N-terminal pro-brain natriuretic peptide; LDL-C, low-density lipoprotein cholesterol; Hs-CRP, high-sensitive C-reactive protein; eGFR, estimated glomerular filtration rate; UACR, urine albumin-to-creatinine ratio. a The estimated glomerular filtration rate was calculated by using the creatinine based CKD-EPI formula.
b The 24 h urinary sodium excretion was estimated by applying Kawasaki's formula. multiple potential confounders. Compared to the lowest quartile, the eGFR of individuals in the highest quartile was significantly lower, as shown in Figure 1 . On the other hand, we did not find a significant association between ET-1 levels and albuminuria, as shown in Table 2 . There were no significant interactions for the association between ET-1 and the eGFR, as shown in Table 3 .
Discussion
This study has several noteworthy findings. First, by applying a novel high-sensitivity assay, we were able to quantify plasma ET-1 levels in a large cohort of young and healthy adults at low cardiovascular risk. Second, our analyses revealed significant relationships of plasma ET-1 with creatinine, cystatin C and eGFR among these individuals without renal or atherosclerotic disease. By including a broad set of important clinical variables to our models, we further reduced the potential for residual confounding.
Earlier studies indicated that the endothelin system, particularly ET-1, directly influence the vasomotor function and thus renal blood flow, which consequently impacts renal function [30, 31] . It has also been shown that the endothelin system plays a key role in common pathophysiological processes involved in most renal disorders, and ET-1, for example, directly promotes mesangial cell proliferation and glomerular sclerosis [21, 32] . Finally, smaller studies including patients with established renal disease have also shown that higher plasma concentrations of ET-1 are inversely associated to measured GFR [33] .
By highlighting a relationship between plasma ET-1 and renal parameters in individuals with a normal function (the median eGFR in this study was 112 mL/ Coefficients were adjusted for sex, age, body mass index, systolic blood pressure, low-density lipoprotein cholesterol, prediabetes/diabetes, high-sensitive C-reactive protein, N-terminal pro-brain natriuretic peptide, estimated urinary sodium excretion, estimated muscle mass, estimated total body water, education level, alcohol consumption, physical activity and current smoking. min/1.73 m 2 ), we are confirming and expanding the existing, mostly experimental based knowledge about the endothelin-system to a population-based setting. Furthermore, it is noteworthy that the relationship between ET-1 and the eGFR remained almost unaffected by adjustment for hs-CRP and NT-pro-BNP, whereas the endothelin system has been shown to trigger inflammation and natriuretic peptides synthesis, which in turn also influence the renal physiology [34, 35] . Hence, this might underscore the independent role of ET-1 in regulating the renal function. Our data actually suggest that ET-1 may be a sensitive marker of kidney blood flow and/or renal function even in adults with high-normal eGFR levels. Future studies should assess whether plasma-derived ET-1 might become a promising biomarker to estimate renal blood flow and function, and to identify individuals at risk for progression of kidney disease.
In this context, one needs to take in account that the prevalence of chronic kidney disease continuously increases with advancing age, affecting more than 20% of all individuals older than 60 years and 35% of those older than 70 years [1, 3, 4] . It is now also well-established that even early-stage renal failure adversely impacts general health and represents an independent cardiovascular risk factor [1, 3, 4] . Consequently, early recognition of adverse renal changes and ultimately prevention of a chronic renal condition, particularly cost-intensive and deadly end-stage renal disease (ESRD), are of utmost clinical importance.
In contrast to our study, earlier studies showed relationships between ET-1 and albuminuria [33, 36] . However, those studies mostly included either elderly individuals or patients with established renal disease, which may influence the described association there [37] . We presume that the earlier shown association between ET-1 and albuminuria might be more important among individuals with advanced renal damage. Additionally, we only had a sample of 52 patients with albuminuria, which might limit the power to show an association. Moreover, this finding could also mean that the relationship between plasma ET-1 and renal parameters in young and healthy adults predominantly reflects renal perfusion and not tubular or glomerular damage.
Strengths of this population based-study are the large and well-characterized cohort of young and healthy individuals and the availability of measurable ET-1 levels in virtually all participants. We are aware of certain limitations which apply to our study: First, the cross-sectional design of this study does not allow to draw causal inferences; second, our study cohort included low risk and mainly white adults and the generalizability to other populations remains unknown; third, we did neither directly The β-coefficients (95% confidence intervals) represent the increase of the estimated glomerular filtration rate (in mL/min/1.73 m 2 ) per unit of log transformed endothelin-1 levels. All coefficients were adjusted for sex, age, body mass index, systolic blood pressure, low-density lipoprotein cholesterol, prediabetes/diabetes, high-sensitive C-reactive protein, N-terminal pro-brain natriuretic peptide, estimated urinary sodium excretion, estimated muscle mass, estimated total body water, education level, alcohol consumption, physical activity and current smoking.
measure the renal function nor invasively estimate the endothelial function. However, the eGFR assessment with the CKD-EPI formula reflects a broadly validated tool for determination renal function, even among young individuals [38] [39] [40] . In addition, it has been shown that levels of ET-1 are closely and directly linked to endothelial dysfunction and presence of atherosclerosis [24, 41] .
